Monocyte-to-High Density Lipoprotein Cholesterol Ratio Positively Predicts Coronary Artery Disease and Multi-Vessel Lesions in Acute Coronary Syndrome

References

• Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013;34(10):719–728. doi:10.1093/eurheartj/ehs411
   PubMed Web of Science ®Google Scholar
• Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125(9):1147–1156. doi:10.1161/circulationaha.111.047431
   PubMed Web of Science ®Google Scholar
• Morrow DA. Cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation. 2010;121(24):2681–2691. doi:10.1161/circulationaha.109.852749
   PubMed Web of Science ®Google Scholar
• Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487(7407):325–329. doi:10.1038/nature11260
   PubMed Web of Science ®Google Scholar
• Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7(2):77–86. doi:10.1038/nrcardio.2009.228
   PubMed Web of Science ®Google Scholar
• Nahrendorf M, Swirski FK. Monocyte and macrophage heterogeneity in the heart. Circ Res. 2013;112(12):1624–1633. doi:10.1161/circresaha.113.300890
   PubMed Web of Science ®Google Scholar
• Dutta P, Nahrendorf M. Monocytes in myocardial infarction. Arterioscler Thromb Vasc Biol. 2015;35(5):1066–1070. doi:10.1161/atvbaha.114.304652
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612–616. doi:10.1126/science.1175202
   PubMed Web of Science ®Google Scholar
• van der Laan AM, Ter Horst EN, Delewi R, et al. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2014;35(6):376–385. doi:10.1093/eurheartj/eht331
   PubMed Web of Science ®Google Scholar
• Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Hemost. 2012;10(7):1231–1241. doi:10.1111/j.1538-7836.2011.04603.x
   Web of Science ®Google Scholar
• Tsujioka H, Imanishi T, Ikejima H, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol. 2009;54(2):130–138. doi:10.1016/j.jacc.2009.04.021
   PubMed Web of Science ®Google Scholar
• Ji H, Li Y, Fan Z, et al. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord. 2017;17(1):90. doi:10.1186/s12872-017-0507-4
   PubMed Web of Science ®Google Scholar
• Li Y, Liu X, Luo Y. Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in Chinese adults: a cross-sectional study. BMC Endocr Disord. 2022;22(1):48. doi:10.1186/s12902-022-00966-z
   PubMed Web of Science ®Google Scholar
• Karatas MB, Canga Y, Ozcan KS, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34(2):240–244. doi:10.1016/j.ajem.2015.10.049
   PubMed Web of Science ®Google Scholar
• Canpolat U, Aytemir K, Yorgun H, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace. 2015;17(12):1807–1815. doi:10.1093/europace/euu291
   PubMed Web of Science ®Google Scholar
• Wang Z, Ren L, Lei L, Ye H, Peng J. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2016;71(2):241–246. doi:10.2143/ac.71.2.3141856
   PubMed Web of Science ®Google Scholar
• Balta S, Celik T, Ozturk C, et al. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction. Am J Emerg Med. 2016;34(8):1542–1547. doi:10.1016/j.ajem.2016.05.031
   PubMed Web of Science ®Google Scholar
• Ucar FM. A potential marker of bare metal stent restenosis: monocyte counts - to- HDL cholesterol ratio. BMC Cardiovasc Disord. 2016;16(1):186. doi:10.1186/s12872-016-0367-3
   PubMedGoogle Scholar
• Açıkgöz SK, Açıkgöz E, Şensoy B, Topal S, Aydoğdu S. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016;23(5):505–512. doi:10.5603/CJ.a2016.0026
   PubMed Web of Science ®Google Scholar
• Ruparelia N, Godec J, Lee R, et al. Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and is identified through conserved transcriptional responses in mice and humans. Eur Heart J. 2015;36(29):1923–1934. doi:10.1093/eurheartj/ehv195
   PubMed Web of Science ®Google Scholar
• Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost. 2011;105(Suppl 1):S34–42. doi:10.1160/ths10-11-0717
   PubMedGoogle Scholar
• Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB. J Biol Chem. 2000;275(2):883–889. doi:10.1074/jbc.275.2.883
   PubMed Web of Science ®Google Scholar
• Selzman CH, Shames BD, McIntyre RC, Banerjee A, Harken AH. The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferation. Ann Thorac Surg. 1999;67(5):1227–31; discussion 31–2. doi:10.1016/s0003-497(99)00252-0
   PubMed Web of Science ®Google Scholar
• Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137(1):49–53. doi:10.1093/oxfordjournals.aje.a116601
   PubMed Web of Science ®Google Scholar
• Arfvidsson J, Ahlin F, Vargas KG, Thaler B, Wojta J, Huber K. Monocyte subsets in myocardial infarction: a review. Int J Cardiol. 2017;231:47–53. doi:10.1016/j.ijcard.2016.12.182
   PubMed Web of Science ®Google Scholar
• Saederup N, Chan L, Lira SA, Charo IF. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation. 2008;117(13):1642–1648. doi:10.1161/circulationaha.107.743872
   PubMed Web of Science ®Google Scholar
• Weber C, Belge KU, von Hundelshausen P, et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol. 2000;67(5):699–704. doi:10.1002/jlb.67.5.699
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in the blood. Blood. 2010;116(16):e74–80. doi:10.1182/blood-2010-02-258558
   PubMed Web of Science ®Google Scholar
• Idzkowska E, Eljaszewicz A, Miklasz P, Musial WJ, Tycinska AM, Moniuszko M. The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes. Scand J Immunol. 2015;82(3):163–173. doi:10.1111/sji.12314
   PubMed Web of Science ®Google Scholar
• Berg KE, Ljungcrantz I, Andersson L, et al. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012;5(1):122–131. doi:10.1161/circgenetics.111.960385
   PubMedGoogle Scholar
• Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence. Arterioscler Thromb Vasc Biol. 2006;26(5):977–986. doi:10.1161/01.ATV.0000204327.96431.9a
   PubMed Web of Science ®Google Scholar
• Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764–772. doi:10.1161/01.res.0000146094.59640.13
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11):2071–2077. doi:10.1161/atvbaha.108.168690
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044(2):275–283. doi:10.1016/0005-2760(90)90314-n
   PubMed Web of Science ®Google Scholar
• Susser LI, Rayner KJ. Through the layers: how macrophages drive atherosclerosis across the vessel wall. J Clin Invest. 2022;132(9). doi:10.1172/JCI157011
   PubMed Web of Science ®Google Scholar
• Toth PP, Barter PJ, Rosenson RS, et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7(5):484–525. doi:10.1016/j.jacl.2013.08.001
   PubMed Web of Science ®Google Scholar
• Drexel H, Amann FW, Rentsch K, et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol. 1992;70(4):436–440. doi:10.1016/0002-9149(92)91186-8
   PubMed Web of Science ®Google Scholar
• Thakkar H, Vincent V, Roy A, et al. HDL functions and their interaction in patients with ST-elevation myocardial infarction: a case-control study. Lipids Health Dis. 2020;19(1):75. doi:10.1186/s12944-020-01260-4
   PubMed Web of Science ®Google Scholar
• Romm PA, Green CE, Reagan K, Rackley CE. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol. 1991;67(6):479–483. doi:10.1016/0002-9149(91)90007-8
   PubMed Web of Science ®Google Scholar
• Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25(11):1077–1086. doi:10.1016/j.hlc.2016.02.023
   PubMed Web of Science ®Google Scholar
• Çiçek G, Kundi H, Bozbay M, Yayla C, Uyarel H. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI. Coron Artery Dis. 2016;27(3):176–184. doi:10.1097/MCA.0000000000000343
   PubMed Web of Science ®Google Scholar
• Ganjali S, Gotto AM, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–9246. doi:10.1002/jcp.27028
   PubMed Web of Science ®Google Scholar
• Ma X, Han K, Yang L, et al. Adjustment of the GRACE risk score by monocyte to high-density lipoprotein ratio improves prediction of adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Front Cardiovasc Med. 2021;8:755806. doi:10.3389/fcvm.2021.755806
   PubMed Web of Science ®Google Scholar
• Oylumlu M, Oylumlu M, Arik B, et al. Monocyte to high-density lipoprotein cholesterol and lymphocyte to monocyte ratios are predictors of in-hospital and long-term mortality in patients with acute coronary syndrome. Int J Clin Pract. 2021;75(5):e13973. doi:10.1111/ijcp.13973
   PubMed Web of Science ®Google Scholar